High Protein Diet on Transcriptomic, Metabolomics, Hepatic and Pancreatic Fat Anatomy and Physiology in Asian Indians With Pre-diabetes
Pre-diabetes
About this trial
This is an interventional prevention trial for Pre-diabetes
Eligibility Criteria
Exclusion Criteria: Acute infections and advanced end-organ damage. History of hepatitis or pancreatitis, abnormal liver and renal function tests. Recent (<3 months) changes in weight (≥5%) and/or weight changing medications. Subjects with metallic implants, pacemaker leads, radioactive seeds or surgical staples in the body. Inclusion Criteria Cases: Age 18 to 50 years. Subjects with pre-diabetes on oral glucose tolerance test (OGTT) Fasting blood glucose≥100mg/dl and <126 mg/dl or 2-h plasma glucose ≥140mg/dl and <200mg/dl (after ingestion of 75 grams of anhydrous oral glucose) or both. Controls: Age 18 to 50 years. Normoglycemia by OGTT Fasting blood glucose <100mg/dl and 2-h plasma glucose <140mg/dl (after ingestion of 75 gram of anhydrous oral glucose).
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Other
High Protein Diet
Control Group
High protein diet (carbohydrates 45%, protein 29%, and fat 26%) over 8-week periods. All assessments as done on day 1 will be repeated on day 60.
Equicaloric normal diet (carbohydrates 60%, protein 15%, and fat 25%)